TrialVaccine2020

Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months.

Xavier Sáez-Llorens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.